For example, CD133+ cells from NSCLC cell lines and primary patient samples have been reported to have the unique ability to generate spheres in vitro and to initiate tumors in immuno-compromised mice [12], [13], [16], [17], [34]. This evidence concerns the gene PROM1 and non-small cell lung carcinoma.